European biologics market is estimated to grow at a CAGR of 7.9% during the forecast period. The major factors contributing to the market growth include the rising approvals of monoclonal antibody drugs and a significant rise in the prevalence of chronic diseases. As per the European Commission, the cancer burden is estimated to have increased to 2.7 million new incidences in EU-27 countries (all kinds, apart from non-melanoma skin cancer) in 2020. This, in turn, is leading to an increasing demand for biologics drugs which acts as an immune system substance that supports to augment the body’s ability to fight against cancer. Types of biological drugs comprise vaccines, allergens, blood, tissues, recombinant proteins, blood components, cells, and genes. Biologic drugs are utilized to treat multiple conditions and are the most available advanced therapies. Apart from cancer, biologic drugs are utilized for the treatment of ulcerative colitis, rheumatoid arthritis, Crohn's disease, and other autoimmune diseases.

Free Sample Copy @ https://www.omrglobal.com/request-sample/european-biologics-market

European biologics market is segmented based on product and application. Based on the product, the market is segmented into antibody therapeutics, vaccines, cell therapy, gene therapy, and others. Increasing focus on approvals of gene therapies is driving the growth of the market. In September 2020, GenSight Biologics presented a marketing application for Lumevoq, its lead gene therapy to the European Medicines Agency (EMA). The company intends to seek approval for Lumevoq (lenadogene nolparvovec) as a therapy for patients suffering from vision loss resulted due to Leber Hereditary Optic Neuropathy (LHON), caused by a mutation in the ND4 mitochondrial gene. Based on application, the market is segmented into cancer, autoimmune diseases, infectious diseases, and others.

A Full Report of European Biologics Market is Available at:
https://www.omrglobal.com/industry-reports/european-biologics-market

The market study of the European biologics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in our reports.

European Biologics Market – Segmentation
by Product
Antibody Therapeutics
Vaccines
Cell Therapy
Gene Therapy
Others
by Application
Cancer
Autoimmune Diseases
Infectious Diseases
Others

European Biologics Market – Segmentation by Region 
Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Company Profiles
AbbVie Inc.
Amgen Inc.
AstraZeneca plc
Baxter International Inc.
Biocon Ltd.
Boehringer Ingelheim GmbH
Bristol Myers Squibb Co.
Eli Lilly and Co.
F. Hoffman-La Roche AG
GlaxoSmithKline PLC
H. Lundbeck A/S
Merck & Co., Inc.
Novo Nordisk A/S
Sanofi SA
Smith & Nephew PLC

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-biologics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404